SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Revuelta, G. J.
Right arrow Articles by Lippa, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Revuelta, G. J.
Right arrow Articles by Lippa, C. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Association Between Progranulin and β-Amyloid in Dementia With Lewy Bodies

Gonzalo J. Revuelta, DO

Department of Neurology, Drexel University College of Medicine, Philadelphia, Pennsylvania

Andrea Rosso, MPH

Department of Neurology, Drexel University College of Medicine, Philadelphia, Pennsylvania

Carol F. Lippa, MD

Department of Neurology, Drexel University College of Medicine, Philadelphia, Pennsylvania, Clippa{at}DrexelMed.edu

Recent studies demonstrated that progranulin plays an integral role in the pathogenesis of frontotemporal dementia. To begin to explore the role of progranulin in dementia with Lewy bodies, we investigate its association with pathologic proteins that characterize this disease. We assessed immunoreactivity for progranulin in medial temporal lobe structures of 12 cases of dementia with Lewy bodies. Similar data were collected for β-amyloid burden, and {alpha}-synuclein pathology. Blinded investigators used a 0-3—point scale to quantify progranulin burden. Double labeling for progranulin and β-amyloid was also performed. We were able to demonstrate progranulin immunoreactivity throughout the medial temporal lobe in all dementia with Lewy body cases. We identified a significant positive correlation (r = 0.606; P = .037) between β-amyloid burden and progranulin. There was no significant correlation between {alpha}-synuclein pathology or Braak stage and progranulin. Progranulin and β-amyloid co-localized in plaques in dementia with Lewy bodies, suggesting that there is likely a biological association between these 2 aggregated proteins.

Key Words: progranulin • β-amyloid • dementia with Lewy bodies • synucleinopathies • frontotemporal dementia

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 23, No. 5, 488-493 (2008)
DOI: 10.1177/1533317508321910


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement